Literature DB >> 1370911

Appropriate chemotherapy for palliating advanced cancer.

R D Rubens1, K E Towlson, A J Ramirez, S Coltart, M L Slevin, C Terrell, A R Timothy.   

Abstract

Entities:  

Mesh：

Year:  1992        PMID： 1370911      PMCID： PMC1880912          DOI： 10.1136/bmj.304.6818.35

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  3 in total

1.  Auditing palliative cancer chemotherapy.

Authors:  R D Rubens
Journal:  Eur J Cancer       Date:  1990       Impact factor: 9.162

2.  BACUP--the first two years: evaluation of a national cancer information service.

Authors:  M L Slevin; Y Terry; N Hallett; S Jefferies; S Launder; R Plant; H Wax; T McElwain
Journal:  BMJ       Date:  1988-09-10

3.  Response of patients in phase II studies of chemotherapy in ovarian cancer: implications for patient treatment and the design of phase II trials.

Authors:  G Blackledge; F Lawton; C Redman; K Kelly
Journal:  Br J Cancer       Date:  1989-04       Impact factor: 7.640
  3 in total
  8 in total

1.  Appropriate chemotherapy for palliating advanced cancer.

Authors:  M S Hamilton
Journal:  BMJ       Date:  1992-02-01

2.  Appropriate chemotherapy for palliating advanced cancer.

Authors:  B Jacobson
Journal:  BMJ       Date:  1992-02-01

Review 3.  [Terminal care medicine--basic principles and perspectives].

Authors:  B Knupp; W Stille
Journal:  Med Klin (Munich)       Date:  1997-02-15

Review 4.  Key issues in the treatment of advanced breast cancer. Expectations and outcomes.

Authors:  R D Rubens
Journal:  Pharmacoeconomics       Date:  1996       Impact factor: 4.981

5.  The last 3 months of life of cancer patients: medical aspects and role of home-care services in southern Switzerland.

Authors:  C Sessa; E Roggero; S Pampallona; S Regazzoni; M Ghielmini; M Lang; B Marx; H Neuenschwander; O Pagani; V Vasilievic; F Cavalli
Journal:  Support Care Cancer       Date:  1996-05       Impact factor: 3.603

6.  Chemotherapy for advanced breast cancer: what influences oncologists' decision-making?

Authors:  E A Grunfeld; A J Ramirez; E J Maher; D Peach; T Young; I P Albery; M A Richards
Journal:  Br J Cancer       Date:  2001-05-04       Impact factor: 7.640

7.  Hospice management of patients receiving cytotoxic chemotherapy: problems and opportunities.

Authors:  F Hicks; G Corcoran
Journal:  Br J Cancer       Date:  1993-12       Impact factor: 7.640

8.  Do patients with advanced breast cancer benefit from chemotherapy?

Authors:  A J Ramirez; K E Towlson; M S Leaning; M A Richards; R D Rubens
Journal:  Br J Cancer       Date:  1998-12       Impact factor: 7.640
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.